Executive Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Executive Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $27,729 - $31,005	479 Added 13.04%	4,153 $241,000
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $254 - $282	4 Added 0.11%	3,674 $234,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $241,155 - $273,525	3,670 New	3,670 $254,000
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $5,346 - $6,338	-125 Reduced 6.6%	1,770 $89,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $14,501 - $16,035	-325 Reduced 14.64%	1,895 $86,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $52,339 - $62,408	-1,160 Reduced 34.32%	2,220 $106,000
Q4 2018 Feb 19, 2019	BUY	$48.76 - $63.23 $164,808 - $213,717	3,380 New	3,380 $176,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Executive Wealth Management, LLC with notifications on news.